Anduril IPO before 2027?

What this market is about

The question is simple: will Anduril list shares on a recognized stock exchange by December 31, 2026 at 11:59 PM ET? A Yes result requires a completed IPO, while a merger, acquisition, or the company ceasing to exist before then would make the answer No under the rules. The market resolves early if the IPO happens, and the stated source of truth is a consensus of credible reporting or official company announcements.

Why the market exists

Anduril is widely watched because it sits at the intersection of defense contracting, autonomous systems, and venture-backed growth, which makes its public-listing timeline especially uncertain. Investors and followers may disagree on whether the company will choose to go public on this timetable, whether market conditions will be favorable, and whether it will stay private longer instead. The current trading shows the market leaning toward No, with a tight spread and meaningful volume suggesting active interest but still real uncertainty.

What can move the price

Price can move if Anduril or credible reporting signals a formal IPO filing, an underwriting process, or a clear public-listing timetable. It can also move if the company raises large private funding, issues statements about remaining private, or if broader market conditions make newly listed defense and technology names look more or less attractive. Any acquisition talk, merger announcement, or evidence that Anduril is changing structure would matter here because the rules treat those outcomes as No unless an IPO happens first.

How to read the current probability